You Can See Everything Eyes Best Documentary Opening Since Fahrenheit 9/11

October 17, 2026

A documentary about Elizabeth Holmes is about to do something documentaries are not supposed to do. You Can See Everything, A24's new film co-directed by Nathan Fielder and Lance Oppenheim, is projected to open with $12–14 million from roughly 855 theaters, according to Deadline's figures as reported by ScreenRant on Saturday. If the projection holds, it is the strongest opening for a non-concert documentary since Michael Moore's Fahrenheit 9/11 in 2004 — a record that has stood through two decades of supposed documentary booms. The full weekend picture is in box office coverage.

The comparisons frame the scale. Fahrenheit 9/11 opened to $23.9 million in a political fever summer; nothing in the non-concert documentary field has come close since. Disney's Chimpanzee managed $10.7 million in 2012, and this year's Melania opened to $7.2 million. You Can See Everything is projected to clear both of those marks while playing in fewer than 900 theaters — a per-theater figure that belongs to event films, not nonfiction. GlobeTV's reporting put the theater count at about 855 and noted the audience skew: 62 percent between 18 and 34, remarkably young for a documentary about a fraud trial. Find the film in the catalog.

The film itself is an audacious construction. Fielder and Oppenheim follow Holmes and her partner Billy Evans across a single month — 34 days, per USA Today's coverage — in the run-up to Holmes beginning her prison sentence. Holmes was sentenced to 11 years for investor fraud in the Theranos collapse, one of the defining corporate scandals of the century. Rather than re-litigating the trial, the filmmakers embedded in the strange suspended interval before incarceration, when a person's old life has ended and the sentence has not yet begun. That premise — part portrait, part countdown — is what audiences are evidently showing up for.

The release strategy manufactured the event. The film premiered as a secret screening at Telluride in September, a rollout choice that converted a documentary into a rumor and then a headline before a single ticket was sold. JoBlo reported $2 million in previews for a film running close to three hours — a runtime that limits showtimes per screen per day, making the projected total more impressive still. GlobeTV, citing Deadline, counted some 1,300 sellouts through Saturday. Scarcity, secrecy and a subject the culture never finished arguing about: the oldest event-movie formula there is, applied to nonfiction. More on the fall slate at Coming Soon.

Audiences are not just attending; they are evangelizing. The film is Rotten Tomatoes Certified Fresh at 99 percent from critics and 99 percent from verified audiences — a symmetry almost unheard of for a film about a convicted fraudster. PostTrak polling reported via Deadline shows 91 percent definite recommend and 98 percent positive overall. Numbers like that describe word of mouth that compounds: each sellout produces a roomful of people who leave arguing about what they saw, which is precisely the conversation Fielder's work is engineered to start. His involvement guarantees the film is doing something stranger than a standard true-crime retelling — and audiences seem to have understood that before critics finished explaining it. Related true-crime titles live in Browse.

For A24, the opening is another data point in the studio's transformation of niche material into theatrical events. The documentary sector has spent years migrating to streaming, on the theory that nonfiction audiences would not leave home. You Can See Everything is the counterexample the theatrical business needed: a documentary can still be a weekend event if it is positioned like one — secret premiere, scarce screens, a subject with unfinished cultural business, and filmmakers whose names function as genres. Expect every distributor with a festival documentary in the vault to study this rollout frame by frame. The desk tracks the fallout, with free documentary picks for home viewing.

The record framing needs one honest caveat, and the trades have kept it intact: the benchmark excludes concert films, which operate in a different commercial universe. Within its proper category, though, the achievement stands — the best documentary opening in 22 years, from 855 theaters, for a three-hour film about a woman awaiting prison. Final weekend numbers land Monday, and the per-theater average will be the figure rival distributors circle. Whatever the final tally, You Can See Everything has already made its point, in the only language Hollywood fully trusts. Follow final grosses in the feed and find Holmes-era coverage in the catalog.

There is a final irony the numbers underline. Theranos sold investors a machine built on secrecy — a black box whose inner workings no one was permitted to examine — and Holmes's mystique was the product as much as the technology ever was. A documentary that turns her final month of freedom into a box-office event, sold through a secret screening and an unknowable three-hour interior, is in some sense the same spell cast honestly: audiences are paying to watch a person who made herself impossible to see. Title notwithstanding, that tension — between the seeing and the not-seeing — is the film's real subject, and the weekend's receipts say the culture is not finished with it.